TY - JOUR A1 - Dumic, Emil A1 - Bjelopera, Anamaria A1 - Nüchter, Andreas T1 - Dynamic point cloud compression based on projections, surface reconstruction and video compression JF - Sensors N2 - In this paper we will present a new dynamic point cloud compression based on different projection types and bit depth, combined with the surface reconstruction algorithm and video compression for obtained geometry and texture maps. Texture maps have been compressed after creating Voronoi diagrams. Used video compression is specific for geometry (FFV1) and texture (H.265/HEVC). Decompressed point clouds are reconstructed using a Poisson surface reconstruction algorithm. Comparison with the original point clouds was performed using point-to-point and point-to-plane measures. Comprehensive experiments show better performance for some projection maps: cylindrical, Miller and Mercator projections. KW - 3DTK toolkit KW - map projections KW - point cloud compression KW - point-to-point measure KW - point-to-plane measure KW - Poisson surface reconstruction KW - octree Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-252231 SN - 1424-8220 VL - 22 IS - 1 ER - TY - JOUR A1 - Duque, Laura A1 - Poelman, Erik H. A1 - Steffan-Dewenter, Ingolf T1 - Plant age at the time of ozone exposure affects flowering patterns, biotic interactions and reproduction of wild mustard JF - Scientific Reports N2 - Exposure of plants to environmental stressors can modify their metabolism, interactions with other organisms and reproductive success. Tropospheric ozone is a source of plant stress. We investigated how an acute exposure to ozone at different times of plant development affects reproductive performance, as well as the flowering patterns and the interactions with pollinators and herbivores, of wild mustard plants. The number of open flowers was higher on plants exposed to ozone at earlier ages than on the respective controls, while plants exposed at later ages showed a tendency for decreased number of open flowers. The changes in the number of flowers provided a good explanation for the ozone-induced effects on reproductive performance and on pollinator visitation. Ozone exposure at earlier ages also led to either earlier or extended flowering periods. Moreover, ozone tended to increase herbivore abundance, with responses depending on herbivore taxa and the plant age at the time of ozone exposure. These results suggest that the effects of ozone exposure depend on the developmental stage of the plant, affecting the flowering patterns in different directions, with consequences for pollination and reproduction of annual crops and wild species. KW - abiotic KW - environmental impact KW - plant ecology Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-265742 VL - 11 IS - 1 ER - TY - JOUR A1 - Dölken, Lars A1 - Stich, August A1 - Spinner, Christoph D. T1 - Remdesivir for Early COVID-19 Treatment of High-Risk Individuals Prior to or at Early Disease Onset — Lessons Learned JF - Viruses N2 - After more than one year of the COVID-19 pandemic, antiviral treatment options against SARS-CoV-2 are still severely limited. High hopes that had initially been placed on antiviral drugs like remdesivir have so far not been fulfilled. While individual case reports provide striking evidence for the clinical efficacy of remdesivir in the right clinical settings, major trials failed to demonstrate this. Here, we highlight and discuss the key findings of these studies and underlying reasons for their failure. We elaborate on how such shortcomings should be prevented in future clinical trials and pandemics. We suggest in conclusion that any novel antiviral agent that enters human trials should first be tested in a post-exposure setting to provide rapid and solid evidence for its clinical efficacy before initiating further time-consuming and costly clinical trials for more advanced disease. In the COVID-19 pandemic this might have established remdesivir early on as an efficient antiviral agent at a more suitable disease stage which would have saved many lives, in particular in large outbreaks within residential care homes. KW - COVID-19 KW - SARS-CoV-2 KW - antiviral treatment KW - remdesivir Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-239648 SN - 1999-4915 VL - 13 IS - 6 ER - TY - JOUR A1 - Döllinger, Nina A1 - Wienrich, Carolin A1 - Latoschik, Marc Erich T1 - Challenges and opportunities of immersive technologies for mindfulness meditation: a systematic review JF - Frontiers in Virtual Reality N2 - Mindfulness is considered an important factor of an individual's subjective well-being. Consequently, Human-Computer Interaction (HCI) has investigated approaches that strengthen mindfulness, i.e., by inventing multimedia technologies to support mindfulness meditation. These approaches often use smartphones, tablets, or consumer-grade desktop systems to allow everyday usage in users' private lives or in the scope of organized therapies. Virtual, Augmented, and Mixed Reality (VR, AR, MR; in short: XR) significantly extend the design space for such approaches. XR covers a wide range of potential sensory stimulation, perceptive and cognitive manipulations, content presentation, interaction, and agency. These facilities are linked to typical XR-specific perceptions that are conceptually closely related to mindfulness research, such as (virtual) presence and (virtual) embodiment. However, a successful exploitation of XR that strengthens mindfulness requires a systematic analysis of the potential interrelation and influencing mechanisms between XR technology, its properties, factors, and phenomena and existing models and theories of the construct of mindfulness. This article reports such a systematic analysis of XR-related research from HCI and life sciences to determine the extent to which existing research frameworks on HCI and mindfulness can be applied to XR technologies, the potential of XR technologies to support mindfulness, and open research gaps. Fifty papers of ACM Digital Library and National Institutes of Health's National Library of Medicine (PubMed) with and without empirical efficacy evaluation were included in our analysis. The results reveal that at the current time, empirical research on XR-based mindfulness support mainly focuses on therapy and therapeutic outcomes. Furthermore, most of the currently investigated XR-supported mindfulness interactions are limited to vocally guided meditations within nature-inspired virtual environments. While an analysis of empirical research on those systems did not reveal differences in mindfulness compared to non-mediated mindfulness practices, various design proposals illustrate that XR has the potential to provide interactive and body-based innovations for mindfulness practice. We propose a structured approach for future work to specify and further explore the potential of XR as mindfulness-support. The resulting framework provides design guidelines for XR-based mindfulness support based on the elements and psychological mechanisms of XR interactions. KW - virtual reality KW - augmented reality KW - mindfulness KW - XR KW - meditation Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-259047 VL - 2 ER - TY - JOUR A1 - Eckardt, Jan-Niklas A1 - Stasik, Sebastian A1 - Kramer, Michael A1 - Röllig, Christoph A1 - Krämer, Alwin A1 - Scholl, Sebastian A1 - Hochhaus, Andreas A1 - Crysandt, Martina A1 - Brümmendorf, Tim H. A1 - Naumann, Ralph A1 - Steffen, Björn A1 - Kunzmann, Volker A1 - Einsele, Hermann A1 - Schaich, Markus A1 - Burchert, Andreas A1 - Neubauer, Andreas A1 - Schäfer-Eckart, Kerstin A1 - Schliemann, Christoph A1 - Krause, Stefan W. A1 - Herbst, Regina A1 - Hänel, Mathias A1 - Frickhofen, Norbert A1 - Noppeney, Richard A1 - Kaiser, Ulrich A1 - Baldus, Claudia D. A1 - Kaufmann, Martin A1 - Rácil, Zdenek A1 - Platzbecker, Uwe A1 - Berdel, Wolfgang E. A1 - Mayer, Jiří A1 - Serve, Hubert A1 - Müller-Tidow, Carsten A1 - Ehninger, Gerhard A1 - Stölzel, Friedrich A1 - Kroschinsky, Frank A1 - Schetelig, Johannes A1 - Bornhäuser, Martin A1 - Thiede, Christian A1 - Middeke, Jan Moritz T1 - Loss-of-function mutations of BCOR are an independent marker of adverse outcomes in intensively treated patients with acute myeloid leukemia JF - Cancers N2 - Acute myeloid leukemia (AML) is characterized by recurrent genetic events. The BCL6 corepressor (BCOR) and its homolog, the BCL6 corepressor-like 1 (BCORL1), have been reported to be rare but recurrent mutations in AML. Previously, smaller studies have reported conflicting results regarding impacts on outcomes. Here, we retrospectively analyzed a large cohort of 1529 patients with newly diagnosed and intensively treated AML. BCOR and BCORL1 mutations were found in 71 (4.6%) and 53 patients (3.5%), respectively. Frequently co-mutated genes were DNTM3A, TET2 and RUNX1. Mutated BCORL1 and loss-of-function mutations of BCOR were significantly more common in the ELN2017 intermediate-risk group. Patients harboring loss-of-function mutations of BCOR had a significantly reduced median event-free survival (HR = 1.464 (95%-Confidence Interval (CI): 1.005–2.134), p = 0.047), relapse-free survival (HR = 1.904 (95%-CI: 1.163–3.117), p = 0.01), and trend for reduced overall survival (HR = 1.495 (95%-CI: 0.990–2.258), p = 0.056) in multivariable analysis. Our study establishes a novel role for loss-of-function mutations of BCOR regarding risk stratification in AML, which may influence treatment allocation. KW - acute myeloid leukemia KW - BCOR KW - BCORL1 KW - loss-of-function KW - risk stratification KW - survival Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-236735 SN - 2072-6694 VL - 13 IS - 9 ER - TY - JOUR A1 - Eckert, Ina N. A1 - Ribechini, Eliana A1 - Jarick, Katja J. A1 - Strozniak, Sandra A1 - Potter, Sarah J. A1 - Beilhack, Andreas A1 - Lutz, Manfred B. T1 - VLA-1 Binding to Collagen IV Controls Effector T Cell Suppression by Myeloid-Derived Suppressor Cells in the Splenic Red Pulp JF - Frontiers in Immunology N2 - Myeloid-derived suppressor cells (MDSCs) represent a major population controlling T cell immune responses. However, little is known about their molecular requirements for homing and T cell interaction to mediate suppression. Here, we investigated the functional role of the homing and collagen IV receptor VLA-1 (α1β1-integrin) on in vitro GM-CSF generated murine MDSCs from wild-type (WT) and CD49a/α1-integrin (Itga1\(^{−/−}\)) gene-deficient mice. Here, we found that effector (Teff) but not naive (Tn) CD4\(^+\) T cells express VLA-1 and monocytes further up-regulated their expression after culture in GM-CSF when they differentiated into the monocytic subset of resting MDSCs (R-MDSCs). Subsequent activation of R-MDSCs by LPS+IFN-γ (A-MDSCs) showed increased in vitro suppressor potential, which was independent of VLA-1. Surprisingly, VLA-1 deficiency did not influence A-MDSC motility or migration on collagen IV in vitro. However, interaction times of Itga1\(^{−/−}\) A-MDSCs with Teff were shorter than with WT A-MDSCs on collagen IV but not on fibronectin substrate in vitro. After injection, A-MDSCs homed to the splenic red pulp where they co-localized with Teff and showed immediate suppression already after 6 h as shown by inhibition of T cell proliferation and induction of apoptosis. Injection of A-MDSCs from Itga1\(^{−/−}\) mice showed equivalent homing into the spleen but a reduced suppressive effect. Interaction studies of A-MDSCs with Teff in the subcapsular red pulp with intravital two-photon microscopy revealed also here that MDSC motility and migration parameters were not altered by VLA-1 deficiency, but the interaction times with Teff were reduced. Together, our data point to a new role of VLA-1 adhesion to collagen IV as a prerequisite for extended contact times with Teff required for suppression. KW - myeloid-derived suppressor cells (MDSCs) KW - T cells KW - VLA-1 KW - homing KW - spleen Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-222671 SN - 1664-3224 VL - 11 ER - TY - JOUR A1 - Egenolf, Nadine A1 - Altenschildesche, Caren Meyer zu A1 - Kreß, Luisa A1 - Eggermann, Katja A1 - Namer, Barbara A1 - Gross, Franziska A1 - Klitsch, Alexander A1 - Malzacher, Tobias A1 - Kampik, Daniel A1 - Malik, Rayaz A. A1 - Kurth, Ingo A1 - Sommer, Claudia A1 - Üçeyler, Nurcan T1 - Diagnosing small fiber neuropathy in clinical practice: a deep phenotyping study JF - Therapeutic Advances in Neurological Disorders N2 - Background and aims: Small fiber neuropathy (SFN) is increasingly suspected in patients with pain of uncertain origin, and making the diagnosis remains a challenge lacking a diagnostic gold standard. Methods: In this case–control study, we prospectively recruited 86 patients with a medical history and clinical phenotype suggestive of SFN. Patients underwent neurological examination, quantitative sensory testing (QST), and distal and proximal skin punch biopsy, and were tested for pain-associated gene loci. Fifty-five of these patients additionally underwent pain-related evoked potentials (PREP), corneal confocal microscopy (CCM), and a quantitative sudomotor axon reflex test (QSART). Results: Abnormal distal intraepidermal nerve fiber density (IENFD) (60/86, 70%) and neurological examination (53/86, 62%) most frequently reflected small fiber disease. Adding CCM and/or PREP further increased the number of patients with small fiber impairment to 47/55 (85%). Genetic testing revealed potentially pathogenic gene variants in 14/86 (16%) index patients. QST, QSART, and proximal IENFD were of lower impact. Conclusion: We propose to diagnose SFN primarily based on the results of neurological examination and distal IENFD, with more detailed phenotyping in specialized centers. KW - algorithm KW - diagnosis KW - neurological examination KW - skin punch biopsy KW - small fiber neuropathy Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-232019 SN - 1756-2864 VL - 14 ER - TY - JOUR A1 - Eichner, Felizitas A. A1 - Reis, Joschua M. A1 - Dores, Joaquim A1 - Pavlovic, Vladimir A1 - Kreß, Luisa A1 - Daneshkhah, Naeimeh A1 - Weinhardt, Renate A1 - Grau, Armin A1 - Mühler, Johannes A1 - Soda, Hassan A1 - Schwarzbach, Christopher J. A1 - Schuler, Michael A1 - Häusler, Karl Georg A1 - Heuschmann, Peter U. T1 - Cross-sectional study on patients' understanding and views of the informed consent procedure of a secondary stroke prevention trial JF - European Journal of Neurology N2 - Background and purpose Improving understanding of study contents and procedures might enhance recruitment into studies and retention during follow-up. However, data in stroke patients on understanding of the informed consent (IC) procedure are sparse. Methods We conducted a cross-sectional study among ischemic stroke patients taking part in the IC procedure of an ongoing cluster-randomized secondary prevention trial. All aspects of the IC procedure were assessed in an interview using a standardized 20-item questionnaire. Responses were collected within 72 h after the IC procedure and analyzed quantitatively and qualitatively. Participants were also asked their main reasons for participation. Results A total of 146 stroke patients (65 ± 12 years old, 38% female) were enrolled. On average, patients recalled 66.4% (95% confidence interval = 65.2%–67.5%) of the content of the IC procedure. Most patients understood that participation was voluntary (99.3%) and that they had the right to withdraw consent (97.1%); 79.1% of the patients recalled the study duration and 56.1% the goal. Only 40.3% could clearly state a benefit of participation, and 28.8% knew their group allocation. Younger age, higher graduation, and allocation to the intervention group were associated with better understanding. Of all patients, 53% exclusively stated a personal and 22% an altruistic reason for participation. Conclusions Whereas understanding of patient rights was high, many patients were unable to recall other important aspects of study content and procedures. Increased attention to older and less educated patients may help to enhance understanding in this patient population. Actual recruitment and retention benefit of an improved IC procedure remains to be tested in a randomized trial. KW - comprehension KW - mixed methods KW - informed consent KW - interview KW - ischemic stroke Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-259404 VL - 28 IS - 8 ER - TY - JOUR A1 - Eidmann, Annette A1 - Ewald, Andrea A1 - Boelch, Sebastian P. A1 - Rudert, Maximilian A1 - Holzapfel, Boris M. A1 - Stratos, Ioannis T1 - In vitro evaluation of antibacterial efficacy of vancomycin-loaded suture tapes and cerclage wires JF - Journal of Materials Science: Materials in Medicine N2 - Usage of implants containing antibiotic agents has been a common strategy to prevent implant related infections in orthopedic surgery. Unfortunately, most implants with microbial repellent properties are characterized by accessibility limitations during daily clinical practice. Aim of this in vitro study was to investigate whether suture tapes and cerclage wires, which were treated with vancomycin, show a sustainable antibacterial activity. For this purpose, we used 24 stainless steel wire cerclages and 24 ultra-high molecular weight polyethylene and polyester suture tape test bodies. The test bodies were incubated for 30 min. in 100 mg/ml vancomycin solution or equivalent volumes of 0.9% NaCl. After measuring the initial solution uptake of the test bodies, antibacterial efficacy via agar diffusion test with Staphylococcus aureus and vancomycin elution tests were performed 1, 2, 3, and 6 days after incubation. Vancomycin-loaded tapes as well as vancomycin-loaded cerclage wires demonstrated increased bacterial growth inhibition when compared to NaCl-treated controls. Vancomycin-loaded tapes showed an additional twofold and eightfold increase of bacterial growth inhibition compared to vancomycin-loaded wires at day 1 and 2, respectively. Elution tests at day 1 revealed high levels of vancomycin concentration in vancomycin loaded tapes and wires. Additionally, the concentration in vancomycin loaded tapes was 14-fold higher when compared to vancomycin loaded wires. Incubating suture tapes and cerclage wires in vancomycin solution showed a good short-term antibacterial activity compared to controls. Considering the ease of vancomycin application on suture tapes or wires, our method could represent an attractive therapeutic strategy in biofilm prevention in orthopedic surgery. KW - anti-bacterial agents / administration & dosage KW - anti-bacterial agents / chemistry KW - bone wires KW - drug liberation KW - materials testing KW - anti-bacterial agents / pharmacology KW - biocompatible Materials KW - prostheses and implants KW - Staphylococcus aureus / drug effects KW - sutures KW - Vancomycin / administration & dosage KW - Vancomycin / chemistry KW - Vancomycin / pharmacology Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-260089 VL - 32 IS - 4 ER - TY - THES A1 - Eiring, Patrick T1 - Super-resolution microscopy of plasma membrane receptors T1 - Hochauflösende Mikroskopie von Plasmamembran Rezeptoren N2 - Plasma membrane receptors are the most crucial and most commonly studied components of cells, since they not only ensure communication between the extracellular space and cells, but are also responsible for the regulation of cell cycle and cell division. The composition of the surface receptors, the so-called "Receptome", differs and is characteristic for certain cell types. Due to their significance, receptors have been important target structures for diagnostic and therapy in cancer medicine and often show aberrant expression patterns in various cancers compared to healthy cells. However, these aberrations can also be exploited and targeted by different medical approaches, as in the case of personalized immunotherapy. In addition, advances in modern fluorescence microscopy by so-called single molecule techniques allow for unprecedented sensitive visualization and quantification of molecules with an attainable spatial resolution of 10-20 nm, allowing for the detection of both stoichiometric and expression density differences. In this work, the single molecule sensitive method dSTORM was applied to quantify the receptor composition of various cell lines as well as in primary samples obtained from patients with hematologic malignancies. The focus of this work lies on artefact free quantification, stoichiometric analyses of oligomerization states and co localization analyses of membrane receptors. Basic requirements for the quantification of receptors are dyes with good photoswitching properties and labels that specifically mark the target structure without generating background through non-specific binding. To ensure this, antibodies with a predefined DOL (degree of labeling) were used, which are also standard in flow cytometry. First background reduction protocols were established on cell lines prior analyses in primary patient samples. Quantitative analyses showed clear expression differences between the cell lines and the patient cells, but also between individual patients. An important component of this work is the ability to detect the oligomerization states of receptors, which enables a more accurate quantification of membrane receptor densities compared to standard flow cytometry. It also provides information about the activation of a certain receptor, for example of FLT3, a tyrosine kinase, dimerizing upon activation. For this purpose, different well-known monomers and dimers were compared to distinguish the typical localization statistics of single bound antibodies from two or more antibodies that are in proximity. Further experiments as well as co localization analyses proved that antibodies can bind to closely adjacent epitopes despite their size. These analytical methods were subsequently applied for quantification and visualization of receptors in two clinically relevant examples. Firstly, various therapeutically relevant receptors such as CD38, BCMA and SLAMF7 for multiple myeloma, a malignant disease of plasma cells, were analyzed and quantified on patient cells. Furthermore, the influence of TP53 and KRAS mutations on receptor expression levels was investigated using the multiple myeloma cell lines OPM2 and AMO1, showing clear differences in certain receptor quantities. Secondly, FLT3 which is a therapeutic target receptor for acute myeloid leukemia, was quantified and stoichiometrically analyzed on both cell lines and patient cells. In addition, cells that have developed resistance against midostaurin were compared with cells that still respond to this type I tyrosine-kinase-inhibitor for their FLT3 receptor expression and oligomerization state. N2 - Plasmamembranrezeptoren sind die wohl wichtigsten und meist untersuchten Komponenten einer Zelle, da sie nicht nur die Kommunikation zwischen dem extrazellulären Bereich und den Zellen gewährleisten, sondern auch für die Regulierung des Zellzyklus und der Zellteilung zuständig sind. Dabei unterscheidet sich die Zusammensetzung der Oberflächenrezeptoren, das sogenannte „Rezeptom“, und ist charakteristisch für bestimme Zelltypen. Aufgrund ihrer Bedeutsamkeit sind Rezeptoren wichtige Zielstrukturen für Diagnose und Therapie in der Krebsmedizin, welche häufig bei verschiedensten Krebserkrankungen im Vergleich zu gesunden Zellen aberrante Expressionsmuster aufweisen. Diese Abweichungen können sich allerdings auch zu Nutze gemacht werden und zum Ziel verschiedener medizinischer Behandlungsmethoden, wie es bei der personalisierten Immuntherapie der Fall ist, werden. Zusätzlich hat der Fortschritt in der modernen Fluoreszenzmikroskopie durch sogenannte Einzelmolekültechniken, es auch erlaubt, eine noch nie dagewesene empfindliche Visualisierung und Quantifizierung von Molekülen mit einer räumlichen Auflösung von 10-20 nm zu erreichen, wodurch sowohl stöchiometrische Unterschiede, als auch Unterschiede in der Expressionsdichte detektiert werden können. In dieser Arbeit wurde die einzelmolekülsensitive Methode dSTORM genutzt, um die Rezeptorkomposition von verschiedenen Zelllinien aber auch von primären Patientenzellen mit zugrundeliegenden hämatologischen Erkrankungen zu quantifizieren. Schwerpunkte dieser Arbeit sind dabei die artefaktfreie Quantifizierung, stöchiometrische Analysen von Oligomerisierungszuständen, sowie die Kolokalisationsanalyse von Membranrezeptoren. Grundvoraussetzung für die Quantifizierung von Rezeptoren sind dabei gut schaltbare Farbstoffe, sowie Label, welche die Zielstruktur spezifisch markieren ohne dabei Hintergrund durch unspezifische Bindung zu generieren. Um dies zu gewährleisten, kamen Antikörper mit einem vordefinierten DOL (degree of labeling; engl. für: Markierungsgrad) zum Einsatz, welche auch in der Durchflusszytometrie standardmäßig eingesetzt werden. Protokolle zur Hintergrundreduktion wurden dabei an Zelllinien etabliert, bevor Primärzellen von Krebspatienten analysiert wurden. Durch quantitative Analysen konnten dabei deutliche Expressionsunterschiede zwischen den Zelllinien und den Patientenzellen, aber auch zwischen den verschiedenen Patienten gezeigt werden. Ein wichtiger Bestandteil dieser Arbeit ist die Fähigkeit, den Oligomerisierungszustand von Rezeptoren zu erkennen, was eine genauere Quantifizierung der Membran-rezeptordichten im Vergleich zur Durchflusszytometrie ermöglicht. Allerdings können diese Oligomerisierungszustände auch Informationen über die Aktivierung eines Rezeptors beinhalten, wie zum Beispiel von FLT3, einer Tyrosinkinase, welche zur Aktivierung dimerisieren muss. Hierfür wurden verschiedene bekannte Monomere und Dimere verglichen, um die typische Lokalisationsstatistik von vereinzelten gebundenen Antikörpern mit der von zwei oder mehr Antikörpern, welche nah beieinanderliegen, zu vergleichen. Durch weitere Etablierungsexperimente sowie Kolokalisationsanalysen konnte außerdem bewiesen werden, dass Antikörper trotz ihrer Größe auch an nah benachbarte Epitope binden können. Diese Analyseverfahren wurden im weiteren Verlauf zur Quantifizierung und Visualisierung von Rezeptoren an zwei klinisch relevanten Beispielen angewendet. Zum einen wurden verschiedene therapeutisch relevante Rezeptoren wie z.B. CD38, BCMA und SLAMF7 für das Multiple Myelom, einer malignen Erkrankung von Plasmazellen, auf Patientenzellen analysiert und quantifiziert. Zusätzlich wurde der Einfluss von TP53 und KRAS Mutationen auf die Rezeptorexpressionen anhand der Multiplen Myelom Zelllinien OPM2 und AMO1 untersucht, bei denen eindeutige Unterschiede in der Rezeptorexpression detektiert wurden. Zum anderen wurde FLT3, welches ein therapeutischer Zielrezeptor für die akute myeloische Leukämie ist, sowohl auf Zelllinien als auch auf Patientenzellen quantifiziert und stöchiometrisch analysiert. Hierbei wurden auch Zellen welche eine Midostaurinresistenz entwickelt haben mit Zellen, welche auf diesen Typ I Tyrosinkinase Inhibitor ansprechen, auf ihre FLT3 Rezeptorexpression und ihren Oligomerisierungszustand verglichen. KW - Fluoreszenzmikroskopie KW - Membranrezeptor KW - Hochaufgelöste Fluoreszenzmikroskopie KW - Super-resolution microscopy KW - Membrane receptor Y1 - 2021 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-250048 ER -